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After years of effort, finally the Cochrane Library has been 
included in the Institute for Scientific Information (ISI) database. 
So, from now on it will be possible to access the Cochrane Library 
impact factor, which is defined by the number of citations over 
a two-year period, divided by the total number of published 
papers in each Journal. This is a simplistic but practical way of 
evaluating the work of researchers in many countries.
Usually the quality of a published paper is evaluated by the 
database in which the journal was published, while assuming 
that it is difficult to publish in many journals that belong to 
the ISI database. However, recent comparison of the quality of 
randomized clinical trials in the five journals with the highest 
impact factor in the field of orthopedics and sports medicine 
that are included in the ISI database showed that, although the 
quality of randomized clinical trials most frequently is higher 
in the ISI than when they are published only in Medline, the 
proportion of papers considered to be good quality within the 
ISI setting of journals was about 40%. In other words, 60% of 
the papers published in the five top journals in the field have 
considerable flaws. So the quality of each published paper 
must be critically appraised individually, and there are lots of 
things to be done regarding the methodology of clinical trials, 
even in ISI journals.
Recently, a new way of evaluating medical journals was 
applied to the 120 top impact-factor ISI journals. McKibbon 
et al.1 (2004) evaluated these journals by looking at the “number 
needed to read” (NNR) index. In other words, how many papers 
need to be read in each “top” journal to find one paper that would 
be considered relevant to the reader and that was also of high meth-
odological quality. Well done! The answer depends on the field of 
knowledge, but in general internal medicine, 95% of the Cochrane 
Library reviews were classified as good quality and relevant, and 
the NNR was 1.1. Among the top medical journals in terms of 
impact factor, New England Journal of Medicine and Lancet had 
an NNR of about 20 papers that needed to be read to be able to 
classify one as relevant and having good methodology.   
It might be said that these authors were more interested 
in systematic reviews. But this is a major interest of medical 
journal readers worldwide. Fortunately, the Cochrane Library 
takes great methodological care and publishes systematic re-
views that are considered to be the best level of evidence for 
decision-making. Probably when the impact factor is calculated 
for the Cochrane Library, we will realize that we have a journal 
with high impact factor and a low “number needed to read” 
and both evaluation tendencies will be satisfied.
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